Based on receptor type, BC was categorized into four groups: HER2+, ER-(progesterone receptor) PR-HER2-, A/B (ER and/or progesterone receptor PR positive and triple-negative breast cancer (TNBC). This evidence concerns the gene PGR and breast cancer.